Healthcare >> CEO Interviews >> November 14, 2011
Kenneth C. Aldrich is Co-Chairman and Co-Founder of International Stem Cell Corporation, a publicly traded regenerative-medicine company. International Stem Cell has created a new class of human stem cells that can do all the things embryonic stem cells can do, but without the ethical issues that arise from the use of human embryos and with the potential to solve the problem of immune rejection in stem cell therapy. Mr. Aldrich has been active in the investment business since 1975, and in early stage venture capital since 1993. He is an active member of Tech Coast Angels, the largest Angel organization in the United States, and has provided early-stage funding and management assistance to a variety of successful startup companies, including WaveTec Vision Systems, Inc. - a VC-backed ophthalmic-device company - and Green Dot Corporation - the world's largest issuer of prepaid debit cards and other banking services to the nation's 70 million unbanked. Green Dot is now listed on the New York Stock Exchange under the symbol GDOT. Mr. Aldrich holds degrees, with honors, from both Harvard University and Harvard Law School and practiced law with the Los Angeles-based firm of O'Melveny & Myers before leaving in 1969 to build a career in finance. Profile
TWST: Let's start with a short history and overview of International Stem Cell Corporation's operations.
Mr. Aldrich: International Stem Cell (ISCO) began back in 2007 as a public company built around
